PMC:7228307 / 4461-4759 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"48","span":{"begin":10,"end":14},"obj":"Gene"},{"id":"61","span":{"begin":225,"end":229},"obj":"Gene"},{"id":"62","span":{"begin":83,"end":87},"obj":"Gene"}],"attributes":[{"id":"A48","pred":"tao:has_database_id","subj":"48","obj":"Gene:2213"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"Gene:2213"},{"id":"A62","pred":"tao:has_database_id","subj":"62","obj":"Gene:2213"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ing of Fc–FcγR interactions.7\nMany therapeutic mAbs depend, to varying degrees, on FcγR function (Figure 1, Table 1) for their mechanism of action (MOA) and/or their pharmacokinetic properties. For some mAbs interaction with FcγR is central to their MOA, such as the destruction of a target cell by"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T24","span":{"begin":291,"end":295},"obj":"Body_part"}],"attributes":[{"id":"A24","pred":"fma_id","subj":"T24","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ing of Fc–FcγR interactions.7\nMany therapeutic mAbs depend, to varying degrees, on FcγR function (Figure 1, Table 1) for their mechanism of action (MOA) and/or their pharmacokinetic properties. For some mAbs interaction with FcγR is central to their MOA, such as the destruction of a target cell by"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T14","span":{"begin":148,"end":151},"obj":"Disease"},{"id":"T15","span":{"begin":250,"end":253},"obj":"Disease"}],"attributes":[{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0016702"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0016702"}],"text":"ing of Fc–FcγR interactions.7\nMany therapeutic mAbs depend, to varying degrees, on FcγR function (Figure 1, Table 1) for their mechanism of action (MOA) and/or their pharmacokinetic properties. For some mAbs interaction with FcγR is central to their MOA, such as the destruction of a target cell by"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T48","span":{"begin":7,"end":9},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T49","span":{"begin":10,"end":12},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T50","span":{"begin":83,"end":85},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T51","span":{"begin":225,"end":227},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T52","span":{"begin":282,"end":283},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T53","span":{"begin":291,"end":295},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"ing of Fc–FcγR interactions.7\nMany therapeutic mAbs depend, to varying degrees, on FcγR function (Figure 1, Table 1) for their mechanism of action (MOA) and/or their pharmacokinetic properties. For some mAbs interaction with FcγR is central to their MOA, such as the destruction of a target cell by"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T22","span":{"begin":88,"end":96},"obj":"http://purl.obolibrary.org/obo/BFO_0000034"},{"id":"T23","span":{"begin":291,"end":295},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"ing of Fc–FcγR interactions.7\nMany therapeutic mAbs depend, to varying degrees, on FcγR function (Figure 1, Table 1) for their mechanism of action (MOA) and/or their pharmacokinetic properties. For some mAbs interaction with FcγR is central to their MOA, such as the destruction of a target cell by"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"48","span":{"begin":10,"end":14},"obj":"Gene"},{"id":"61","span":{"begin":225,"end":229},"obj":"Gene"},{"id":"62","span":{"begin":83,"end":87},"obj":"Gene"}],"attributes":[{"id":"A48","pred":"pubann:denotes","subj":"48","obj":"Gene:2213"},{"id":"A61","pred":"pubann:denotes","subj":"61","obj":"Gene:2213"},{"id":"A62","pred":"pubann:denotes","subj":"62","obj":"Gene:2213"}],"text":"ing of Fc–FcγR interactions.7\nMany therapeutic mAbs depend, to varying degrees, on FcγR function (Figure 1, Table 1) for their mechanism of action (MOA) and/or their pharmacokinetic properties. For some mAbs interaction with FcγR is central to their MOA, such as the destruction of a target cell by"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T25","span":{"begin":30,"end":193},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ing of Fc–FcγR interactions.7\nMany therapeutic mAbs depend, to varying degrees, on FcγR function (Figure 1, Table 1) for their mechanism of action (MOA) and/or their pharmacokinetic properties. For some mAbs interaction with FcγR is central to their MOA, such as the destruction of a target cell by"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T24","span":{"begin":291,"end":295},"obj":"Body_part"}],"attributes":[{"id":"A24","pred":"fma_id","subj":"T24","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ing of Fc–FcγR interactions.7\nMany therapeutic mAbs depend, to varying degrees, on FcγR function (Figure 1, Table 1) for their mechanism of action (MOA) and/or their pharmacokinetic properties. For some mAbs interaction with FcγR is central to their MOA, such as the destruction of a target cell by"}

{"project":"LitCovid-sentences","denotations":[{"id":"T25","span":{"begin":30,"end":193},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ing of Fc–FcγR interactions.7\nMany therapeutic mAbs depend, to varying degrees, on FcγR function (Figure 1, Table 1) for their mechanism of action (MOA) and/or their pharmacokinetic properties. For some mAbs interaction with FcγR is central to their MOA, such as the destruction of a target cell by"}